Address	3101 Western Avenue Seattle Washington 98121 United States
Employees	-
Website	http://www.ctibiopharma.com
Updated	07/08/2019
CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A.